Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company.
Secondary sales in the retail segment grew by 34.2%. Sales leaders are the anti-inflammatory analgesic Ibuprofen and Diclofenac.
JSC “Synthesis” produces about 300 million packages of medications a year. More than 35% of products produced from a private pharmaceutical substances.